Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...

As 1 out of every 3 adults worldwide suffers from the condition, Hebrew University scientists use non-psychoactive substances ...

A new scientific study reveals that two key cannabis compounds work by creating a backup energy reserve in the liver. The post Study reveals cannabis compounds reduce threat of fatty liver disease ...

A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...

Researchers have discovered that non-psychoactive cannabis compounds, CBD and CBG, can significantly reduce liver fat and ...

Sorbitol, a common sugar alcohol used in zero-calorie foods and found naturally in some fruits, isn’t just a passive ...

CBD and CBG, two non-intoxicating cannabis compounds, may help combat fatty liver disease by boosting liver energy reserves ...

A high-fat diet, especially one high in saturated fat and part of an overall high-calorie diet, can increase the risk of ...

Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk.

In experiments on pigs, researchers found that some formula fats can strain the newborn liver far earlier than expected.

A new machine learning model built using a simple and interpretable approach predicts in-hospital death in patients with acute liver failure and reveals top risk drivers.

A 56-year-old man with liver failure has become the first living person to be surgically connected to a genetically modified ...